International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7927832
Original Article
A study of Clinical Profile and Management of Amitraz Poisoning: A Case Series of Not So (UN) Common Poisoning
 ,
 ,
Published
May 12, 2023
Abstract
Introduction: Amitraz is a formamidine pesticide that is used to treat generalised demodicosis in dogs as well as to manage ticks and mites on cattle and sheep. The stimulatory actions of the a2 agonist in amitraz cause its neurotoxic and preconvulsant effects. Aim: To study the clinical features, complications, management and outcome of the patients with acute amitraz intoxication. Material and Methods: Our study is a prospective cross sectional study done on 10 cases presented in emergency medicine department of GMC Miraj. Result: Patients had CNS involvement, miosis/mydriasis, hypotension, bradycardia/tachycardia and nonspecific complaints like pain abdomen, vomiting etc. Gastric lavage was given to every case of amitraz poisoning. Conclusion: In patients who presented with history of pesticide consumption with features of bradycardia, drowsiness and features similar to organophosphorous poison physician should think of amitraz poisoning that will help to initiate rapid treatment for this rare, potentially life threatening intoxication.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
371 Views
103 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved